Posters
Transplantation: Clinical - Rejection, Biomarkers, and Pharmacology
October 23, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Graft Survival in Different Kidney Allograft Rejection Phenotypes: An Analysis of 2,166 Biopsies
Kidney Biopsy Inflammatory Phenotype Differentiates T-Cell-Mediated Rejection (CMR) from Polyomavirus Nephropathy (PVN)
Significance of Borderline Rejection in Protocol Biopsies in Kidney Transplantation
Nephrologist Perceptions of Unmet Needs in the Treatment of Antibody-Mediated Rejection: Results from a Real-World Survey in Germany and the United States
Effect of Current Antibody-Mediated Rejection (AMR) Treatments on Microvascular Inflammation (MVI) in Kidney Transplant Recipients: A Rapid Literature Review (RLR) and Meta-Analysis
A Banff Antibody-Mediated Rejection Gray Zone: Peritubular Capillaritis with C4d Positivity and T-Cell-Mediated Rejection
Beyond Microvascular Inflammation: Banff Activity Index Trajectories Improve Risk Stratification After Antibody-Mediated Rejection
Beyond Diagnosis: Post-Treatment Histological Phenotypes Improve Risk Stratification in Antibody-Mediated Rejection
GFR Trends with Tocilizumab Therapy for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients: A Single-Center Experience
The Donor-Specific Antibody-Negative Paradox: Early Mixed Rejection with Microvascular Inflammation
Mixed Acute Rejection with Plasma Cell Infiltration Responding to Bortezomib in a Kidney Transplant Recipient
Eculizumab as a Rescue Therapy for Early Antibody-Mediated Rejection After Kidney Transplantation
Tubular Secretory Function and Tubular Biomarkers in Living Kidney Donors: A Pilot Study
Urinary Biomarkers Are Associated with Distinct Functional and Histologic Patterns of Kidney Allograft Injury
Urinary Transcriptomics Reveals a Novel Connection Between Tubulointerstitial Fibrosis and Albuminuria in Kidney Transplant Recipients
Urinary CXCL10 Detects Active Tubulointerstitial Inflammation in Kidney Transplant Rejection Missed by Donor-Derived Cell-Free DNA
Donor Plasma IGFBP-7 Is Associated with Post-Transplant Kidney Function and Graft Survival
Cluster-Guided Models for Patient-Specific Subclinical Rejection Surveillance
Integrating Donor-Derived Cell-Free DNA for the Detection of Kidney Allograft Rejection Under the Banff 2024 Framework: An Extended Multinational Validation Study
Association of Donor-Derived Cell-Free DNA Elevation with Outcomes in Borderline and T-Cell-Mediated Rejection (TCMR)
Association of Serum Uric Acid with Donor-Derived Cell-Free DNA and Inflammatory Plasma Proteins in Kidney Allograft Recipients
Progressive Subthreshold Donor-Derived Cell-Free DNA Rise as a Marker of Alloimmunogenic Kidney Allograft Injury
Association Between Tutivia Biomarker Scores and Clinically Defined Immune States in Kidney Transplant Recipients
Histopathological Correlates and Diagnostic Utility of Donor-Derived Cell-Free DNA in Kidney Allograft Injury
Donor-Derived Cell-Free DNA in Kidney Transplant Recipients with Recurrent Lupus Nephritis
Elevated Donor-Derived Cell-Free DNA in Recurrent Lupus Nephritis After Kidney Transplantation: A Case Report
Comparison of SGLT2 Inhibitor with GLP-1 Receptor Agonist vs. SGLT2 Inhibitor Alone in Kidney Transplant Recipients: Real-World Data of 1,915 Cases
Prescription Patterns of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors in Kidney Transplant Recipients: A Real-World Analysis
SGLT2 Inhibitors After Kidney Transplantation: A Single-Center Experience
Effects of SGLT2 Inhibitors on Change in Glomerular Filtration Rate in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
Safety and Efficacy of SGLT2 Inhibitors in Kidney Transplant Recipients in the Saudi Population
Beyond Native Kidneys: The Emerging Role of SGLT2 Inhibitors in Kidney Transplant Recipients
CKD Management After Lung Transplantation: Do SGLT2 Inhibitors Have a Role?
GLP-1 Receptor Agonists in Kidney Transplant Recipients with Obesity and Type 2 Diabetes: A Case Report
Assessment of Efficacy and Safety of Desensitization Therapy with Intravenous Immunoglobulin in Preformed Donor-Specific Antibody-Positive Kidney Transplant Patients
New Desensitisation Strategy: A Case Series of Daratumumab in Highly Sensitised Kidney Transplant Candidates
B-Cell Maturation Antigen-Targeted T-Cell Engager Therapy with Cizutamig for HLA Desensitization in Highly Sensitized Kidney Transplant Candidates
B-Cell Maturation Antigen-Targeted Therapy Enables HLA-Incompatible Combined Haploidentical Stem-Cell and Kidney Transplantation
Comparative Effectiveness and Harms of Belatacept vs. Tacrolimus Among Kidney Transplant Recipients
Everolimus-Based Regimens and Cytomegalovirus Infection Suppression in Kidney Transplantation: Meta-Analysis of Randomized Controlled Trials
Effect of Calcineurin Inhibitor Neurotoxicities on Quality of Life in Kidney Transplant Recipients: Evidence from a Real-World Survey
Limited Association Between Trough-Based Tacrolimus Exposure Metrics and One-Year Kidney Allograft Function: A Multicentre Cohort Study
Beyond Tacrolimus Trough Levels: Area Under the Curve-Based Monitoring in Guatemalan Kidney Transplant Recipients
Fast Tacrolimus Metabolism Is Associated with BK Virus Infection in Kidney Transplant Recipients
Tacrolimus-Associated Severe Hypercalcemia After Living-Related Kidney Transplantation: A Case Report
Subtherapeutic Tacrolimus Trough Levels in the Setting of Radiotherapy: A Case Report
Tacrolimus-Induced Cardiomyopathy in a Kidney Transplant Recipient: A Reversible Cause of Left Ventricular Hypertrophy
Can Sirolimus Cause Delayed Pericardial Effusion?
Unexplained Recurrent Pericardial Effusion in an Organ Transplant Recipient: Think of Zebras
When the Cure Causes Pain: Calcineurin Inhibitor Pain Syndrome Masquerading as Fibromyalgia After Kidney Transplantation
A Rare Case of Cetuximab-Associated Nephrotic-Range Proteinuria and Hypertension in a Kidney Transplant Recipient
Post-Transplant Atypical Hemolytic Uremic Syndrome Outcomes with Eculizumab and Ravulizumab: A Single-Center Experience
Immunosuppression Management and Outcomes After Kidney Graft Failure
To Stop or Not to Stop Immunosuppression: Outcomes of 215 Critically Ill Kidney Transplant Recipients over 14 Years
Efficacy and Safety of Pegmolesatide on Post-Transplant Anemia in Kidney Transplant Recipients: A Retrospective Comparative Cohort Study
Concordance Between Concentration-to-Dose Ratio and CYP3A5 Genotype and Effect on Pharmacokinetics in Kidney Transplant Recipients Receiving Immediate-Release Tacrolimus
Use of Multistrain Probiotic Preparation in Patients in the Early Period After Kidney Transplantation: Results of a Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Trial
Improvement of Calciphylaxis Lesions with Tocilizumab, a US Food and Drug Administration (FDA)-Approved IL-6R Inhibitor, in a Patient with CKD
Clinical Application of PIRCHE Scores: Reclassifying Immunologic Risk in Patients with Medium Eplet Mismatch